APGE vs GILD: Which Stock is Better?
Side-by-side comparison of Apogee Therapeutics Inc and Gilead Sciences Inc in 2026
APGE
Apogee Therapeutics Inc
$74.68
GILD
Gilead Sciences Inc
$146.00
Key Metrics Comparison
| Metric | APGE | GILD | Winner |
|---|---|---|---|
| Market Cap | $5.19B | $184.43B | GILD |
| P/E Ratio | N/A | 21.94 | GILD |
| EPS (TTM) | $N/A | $6.77 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze APGE
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APGE or GILD a better investment?
Comparing APGE and GILD: Apogee Therapeutics Inc has a market cap of $5.19B while Gilead Sciences Inc has $184.43B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APGE and GILD?
APGE (Apogee Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APGE or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APGE or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for APGE.
Which company is more profitable: APGE or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for APGE.
Which is the larger company: APGE or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $184.43B compared to $5.19B for APGE.
Should I buy APGE or GILD in 2026?
Both APGE and GILD have investment merit. APGE trades at $74.68 while GILD trades at $146.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APGE and GILD stock?
Key differences: Market Cap ($5.19B vs $184.43B), P/E Ratio (N/A vs 21.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).